Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT06413654 Not yet recruiting - Clinical trials for Neuromyelitis Optica Spectrum Disorders

A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

Start date: June 20, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

To evaluate the efficacy and safety of B001 injection in aquaporin-4 antibody positive patients with neuromyelitis optica spectrum disorder.

NCT ID: NCT06413602 Not yet recruiting - Multiple Sclerosis Clinical Trials

The Synergistic Effects of AIH and FES in Persons With MS

Start date: August 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to examine how neuromuscular electrical stimulation (NMES), may synergistically enhance corticospinal excitability in people with relapsing form multiple sclerosis (MS). This is an important intermediate step to evaluate the potential of AIH + NMES as a plasticity-priming strategy for more efficacious interventions for persons with MS. This study will measure ankle torque generation and amplitude of motor evoked potentials (MEPs) using a repeated measures study design in order to better understand the effects of AIH combined with NMES, as compared to only receiving NMES, and only receiving AIH.

NCT ID: NCT06413524 Not yet recruiting - COPD Clinical Trials

The Effects of Different Vibration Exercises on COPD Patients

Start date: May 21, 2024
Phase: N/A
Study type: Interventional

Pulmonary rehabilitation is effective in improving exercise tolerance, dyspnea, and fatigue in patients with COPD, and exercise training is an important component of pulmonary rehabilitation. Vibration training can be used as a supplement or alternative to traditional exercise and is a short, safe rehabilitation training. COPD patients will be recruited and randomly assigned to the control group, whole-body vibration training group, or local vibration training group. The study aims to confirm the rehabilitative benefits of enhancing lower limb muscle strength, exercise endurance, and the quality of life related to COPD in patients.

NCT ID: NCT06413225 Not yet recruiting - Clinical trials for Cervical Degenerative Disc Disease

Post-Market Data Collection Protocol to Evaluate the Performance of the Synergy Disc®

Start date: September 1, 2024
Phase:
Study type: Observational

This is a real world data collection observational study at a single site. There are both prospective and retrospective cohorts. The study will examine the safety and effectiveness of the Synergy cervical disc system in patients with degenerative cervical disc disease.

NCT ID: NCT06413173 Not yet recruiting - Clinical trials for Mild Cognitive Impairment

Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The proposed study will evaluate a new approach to cognitive rehabilitation of mTBI using a brain stimulation technique called "Remotely Supervised Transcranial Direct Current Stimulation combined with Cognitive Training" (RS-tDCS+) which has shown promise for improving complex attention in both healthy and clinical populations. RS-tDCS+ is a home-based, low-risk, non-invasive technique that is designed to boost cognitive training by enhancing learning and the brain's ability to reorganize connections. This study will evaluate RS-tDCS+ for improving complex attention in Active Duty Service Members (ADSM) and Veterans with a history of mTBI. Different tests of complex attention and symptom questionnaires will be used to determine the effects of real versus sham (placebo) RS-tDCS+. Second, the investigators will investigate electrical and connectivity changes in the brain associated with RS-tDCS+ using electroencephalogram (EEG) and magnetic resonance imaging (MRI). Third, the investigators will investigate the lasting effects of any observed changes by evaluating participants at 1 and 6 weeks post-treatment. Lastly, the investigators will explore the impact of individual differences (e.g., PTSD, depression, sleep quality, time since injury, baseline impairment, age, sex, ADSM versus Veteran) on treatment outcome.

NCT ID: NCT06412666 Not yet recruiting - Pediatric Clinical Trials

A Study to Evaluate the Effect of Aficamten in Pediatric Patients (Age 12 to <18 Years) With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

CEDAR-HCM
Start date: May 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety and PK of aficamten in a pediatric population with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).

NCT ID: NCT06412068 Not yet recruiting - Clinical trials for Primary Mediastinal Large B Cell Lymphoma

A Prospective Study: Sintilimab and R-CHOP in PMBCL Treatment

Start date: June 1, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this multi-center, single arm, phase Ⅱ clinical trail is to evaluate the efficacy and toxicity of sintilimab combined with R-CHOP regimen as first-line treatment for primary mediastinal large B-cell Lymphoma (PMBCL)

NCT ID: NCT06411665 Not yet recruiting - Clinical trials for Postoperative Nausea and Vomiting

Effect of Oliceridine Analgesia on Postoperative Nause and Vomiting

Start date: June 2024
Phase: Phase 4
Study type: Interventional

Postoperative nausea and vomiting (PONV) is common after surgery and impede rapid recovery after surgery. Patients who undergo laparoscopic colorectal surgery are more likely to develop PONV due to the pneumoperitoneum, interruption of gastrointestinal system, delay of oral feeding, and nasogastric catheterization, as well as postoperative opioid analgesic requirement to control acute pain. Oliceridine is a novel selective μ-opioid agonist. It stimulates G protein signalling but is markedly less potent than morphine for β-arrestin recruitment; the latter contributes to opioid-related adverse events including PONV. It is postulated that G protein-biased agonists may deliver effective analgesia with fewer opioid-related adverse events. This randomized trial aimed to investigate whether oliceridine for patient-controlled analgesia can decrease the incidence of PONV in patients recovering from laparoscopic colorectal surgery.

NCT ID: NCT06411626 Not yet recruiting - Clinical trials for Paroxysmal Nocturnal Hemoglobinuria

Home Reported Outcomes in PNH

Start date: June 15, 2024
Phase:
Study type: Observational

The study aims to longitudinally capture the full spectrum of symptoms, treatment utilization, and overall Health-Related Quality of Life (HRQoL) experienced by PNH patients. By primarily utilizing home reported outcomes (HRO) data on symptom burden and treatment usage, supplemented with patient-reported outcome (PRO) measures, the study seeks to establish a new real-world data (RWD) source to understand symptom variability and HRQoL among PNH patients, including those receiving orally administered iptacopan.

NCT ID: NCT06410664 Not yet recruiting - Clinical trials for VAP - Ventilator Associated Pneumonia

Efficiency and Safety of the Prolonged Use of Heat and Moisture Exchangers in ICU

FILTRex
Start date: May 2024
Phase: N/A
Study type: Interventional

FILTRex is a single-centre, controlled, randomised, prospective, non-inferiority clinical trial to compare the efficiency and safety of prolonged (72-hours) versus standard (24-hours) duration of use for Heat and Moisture Exchange (HME) filters in adult mechanically ventilated critically ill patients